Acer Therapeutics Inc Warrant
ACERW
ACERW was delisted on the 5th of April, 2018.
5 hedge funds and large institutions have $10K invested in Acer Therapeutics Inc Warrant in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
88% less capital invested
Capital invested by funds: $86K → $10K (-$76K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$3.41K |
| 2 |
Bank of New York Mellon
New York
|
+$1.51K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$13.5K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Bank of New York Mellon
New York
| $4K | +$1.51K | +45,593 | +15% |
|
2
California Public Employees Retirement System
Sacramento,
California
| $3K | – | – | – |
|
|
TSS
3
Two Sigma Securities
New York
| $2K | +$3.41K | +102,677 | +275% |
|
|
VF
4
Virtu Financial
New York
| $1K | -$13.5K | -407,587 | -90% |
|
|
5
UBS Group
Zurich,
Switzerland
| – | -$1.6K | -48,120 | -88% |
|
ACERW Hedge Fund Activity: Q4 2017 in Review
5 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc Warrant (ACERW) for Q4 2017, worth a combined $10K — down 88% from $86K a quarter earlier.
Fund positioning in ACERW was balanced in Q4 2017: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 2 trimmed.
The largest buyer was Two Sigma Securities, adding an estimated $3.41K. The largest seller was Virtu Financial, cutting an estimated $13.5K.
- 5 institutional investors held Acer Therapeutics Inc Warrant (ACERW) as of Q4 2017, unchanged from Q3 2017.
- Funds reported $10K of Acer Therapeutics Inc Warrant stock for Q4 2017, down 88% quarter-over-quarter.
- 0 funds opened new Acer Therapeutics Inc Warrant positions in Q4 2017 and 0 closed out.
- The largest Acer Therapeutics Inc Warrant buyer in Q4 2017 was Two Sigma Securities, an estimated $3.41K added.
- The largest Acer Therapeutics Inc Warrant seller in Q4 2017 was Virtu Financial, an estimated $13.5K sold.
Based on aggregated 13F filings for Q4 2017.